SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $519,380,257 |
| Positions | 7 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| PHARVARIS N V | PHVS | COM | $160,569,809 | 4,643,430 |
| PARABILIS MEDICINES INC | PBLS | COM | $144,149,497 | 5,266,697 |
| ALUMIS INC | ALMS | COM | $127,429,401 | 4,528,408 |
| ACHIEVE LIFE SCIENCE INC | ACHV | COM | $38,623,122 | 5,914,720 |
| ALX ONCOLOGY HLDGS INC | ALXO | COM | $26,671,201 | 12,884,638 |
| HARMONY BIOSCIENCES HLDGS IN | HRMY | COM | $17,192,584 | 472,194 |
| LYELL IMMUNOPHARMA INC | LYEL | COM NEW | $4,744,643 | 337,697 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.